Simon Rule, Martin Dreyling, Andre Goy, Georg Hess, Rebecca Auer, Brad Kahl, José-Ángel Hernández-Rivas, Keqin Qi, Sanjay Deshpande, Lori Parisi, and Michael Wang. 2019. “Ibrutinib for the Treatment of relapsed/refractory Mantle Cell Lymphoma: Extended 3.5-Year Follow up from a Pooled Analysis”. Haematologica 104 (5). Pavia, Italy, e211-e214. https://doi.org/10.3324/haematol.2018.205229.